Healthcare Executive Passes Out at Oval Office Announcement
Gordon Findlay, the Healthcare Executive of Novo Nordisk, fainted during an Oval Office event on Thursday focused on weight loss medications.
Incident During GLP-1 Event
The event, which highlighted GLP-1 obesity drugs, was paused as attention shifted to Findlay’s condition. President Donald Trump and Dr. Mehmet Oz noticed the situation immediately.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted,” said White House Press Secretary Karoline Leavitt. “The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Details of the Announcement
President Trump revealed a new agreement with Eli Lilly and Novo Nordisk to offer some obesity drugs to Americans at an estimated cost of $150 for a one-month supply.
Medical Response and Event Resumption
- Findlay passed out during the speech of Eli Lilly CEO David Ricks.
- Press personnel were quickly evacuated from the room.
- Dr. Kennedy exited to seek medical assistance.
- The press conference resumed by 1:29 p.m.
Official Comments
White House Deputy Press Secretary Kush Desai reported on the swift medical response and resumption of the event.
“The White House Medical Unit quickly jumped into action, and the gentleman is okay.”
Summary: During a White House announcement on affordable obesity drugs, Novo Nordisk executive Gordon Findlay fainted but recovered quickly, allowing the event to continue smoothly.